Endoscopic severity and classification of lesions with pan-enteric capsule endoscopy and ileocolonoscopy in ileocolonic Crohn’s disease

Jacob Broder Brodersen; Jens Kjeldsen; Torben Knudsen; Michael Dam Jensen

doi:10.1055/a-1978-6586

Endoscopy International Open, Table of Contents

CC BY-NC-ND 4.0 · Endosc Int Open 2023; 11(01): E32-E38
DOI: 10.1055/a-1978-6586

Original article

Endoscopic severity and classification of lesions with pan-enteric capsule endoscopy and ileocolonoscopy in ileocolonic Crohn’s disease

Jacob Broder Brodersen

¹Department of Internal Medicine, Section of Gastroenterology, Hospital of South West Jutland, Esbjerg, Denmark

²Department of Regional Health Research, University of Southern Denmark, Denmark

,

Jens Kjeldsen

³Department of Medical Gastroenterology, Odense University Hospital, Odense, Denmark

⁴Research Unit of Medical Gastroenterology, Department of Clinical Research, University of Southern Denmark, Odense, Denmark

⁵OPEN Odense Patient data Explorative Network, Odense University Hospital, Odense, Denmark

,

Torben Knudsen

¹Department of Internal Medicine, Section of Gastroenterology, Hospital of South West Jutland, Esbjerg, Denmark

²Department of Regional Health Research, University of Southern Denmark, Denmark

,

Michael Dam Jensen

²Department of Regional Health Research, University of Southern Denmark, Denmark

⁶Department of Internal Medicine, Section of Gastroenterology, Lillebaelt Hospital, Vejle, Denmark

› Author Affiliations

Abstract

Background and study aims Recent evidence supports the use of pan-enteric capsule endoscopy (CE) for the diagnosis and follow-up of Crohn’s disease (CD). The aim of this study was to examine the agreement between CE and ileocolonoscopy (IC) for determining the severity and classification of lesions in ileocolonic CD.

Patients and methods In a prospective blinded multicenter study, patients with suspected CD were examined with CE and IC within 2 weeks. Ninety-nine participants with a full IC and CE were included in the analysis. The ileocolonic disease severity was assessed with the Simple Endoscopic Score for Crohn’s Disease (SES-CD).

Results CD was diagnosed in 30 patients with IC and CE. The mean SES-CD was 9.8 (CI 7.9–11.8) and 10.6 (CI 8.2–13.1), respectively (P = 0.69). There was a substantial agreement (ICC 0.83, CI 0.68–0.92) and a strong correlation between SES-CD assessed with IC and CE (r_s = 0.78, P < 0.001). 55 bowel segments had ulcerations with both modalities (terminal ileum 24, right colon 12, transverse colon eight, left colon eight and rectum three). Mean sub-scores for ulcer size, area of ulcerated surface and area of affected surface did not differ between modalities. The inter-modality agreement (κ) was 0.46, 0.34 and 0.43, respectively (P < 0.001).

Conclusions There is a strong correlation between IC and CE for the severity of ileocolonic CD. The agreement for SES-CD sub-scores is fair to moderate. CE could be an alternative to IC for the assessment of endoscopic severity in selected patients with suspected CD.

Full Text

References

References
1 Maaser C, Sturm A, Vavricka SR. et al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications. J Crohns Colitis 2019; 13: 144-164
2 Early DS, Lightdale JR. ASGE Standards of Practice Committee. et al. Guidelines for sedation and anesthesia in GI endoscopy. Gastrointest Endosc 2018; 87: 327-337
3 Kothari ST, Huang RJ, Shaukat A. et al. ASGE review of adverse events in colonoscopy. Gastrointest Endosc 2019; 90: 863-876e833
4 Brodersen JB, Knudsen T, Kjeldsen J. et al. Diagnostic accuracy of pan-enteric capsule endoscopy and magnetic resonance enterocolonography in suspected Crohnʼs disease. United Europ Gastroenterol J 2022;
5 Jensen MD, Nathan T, Rafaelsen SR. et al. Diagnostic accuracy of capsule endoscopy for small bowel Crohn's disease is superior to that of MR enterography or CT enterography. Clin Gastroenterol Hepat 2011; 9: 124-1296
6 D'Haens G, Lowenberg M, Samaan MA. et al. Safety and feasibility of using the second-generation pillcam colon capsule to assess active colonic Crohnʼs disease. Clin Gastroenterol Hepat 2015; 13: 1480-1486e1483
7 Leighton JA, Helper DJ, Gralnek IM. et al. Comparing diagnostic yield of a novel pan-enteric video capsule endoscope with ileocolonoscopy in patients with active Crohn's disease: a feasibility study. Gastrointest Endosc 2017; 85: 196-205e1918
8 Bruining DH, Oliva S, Fleisher MR. et al. Panenteric capsule endoscopy versus ileocolonoscopy plus magnetic resonance enterography in Crohnʼs disease: a multicentre, prospective study. BMJ Open Gastroenterol; 2020: 7
9 Gralnek IM, Defranchis R, Seidman E. et al. Development of a capsule endoscopy scoring index for small bowel mucosal inflammatory change. Alimentary pharmacology & therapeutics 2008; 27: 146-154
10 Niv Y, Ilani S, Levi Z. et al. Validation of the Capsule Endoscopy Crohnʼs Disease Activity Index (CECDAI or Niv score): a multicenter prospective study. Endoscopy 2012; 44: 21-26
11 Niv Y, Gal E, Gabovitz V. et al. Capsule Endoscopy Crohnʼs Disease Activity Index (CECDAIic or Niv Score) for the small bowel and colon. J Clin Gastroenterol 2018; 52: 45-49
12 Mary JY, Modigliani R. Development and validation of an endoscopic index of the severity for Crohnʼs disease: a prospective multicentre study. Groupe d'Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID). Gut 1989; 30: 983-989
13 Daperno M, DʼHaens G, Van Assche G. et al. Development and validation of a new, simplified endoscopic activity score for Crohnʼs disease: the SES-CD. Gastrointest Endosc 2004; 60: 505-512
14 Annese V, Daperno M, Rutter MD. et al. European evidence based consensus for endoscopy in inflammatory bowel disease. J Crohns Colitis 2013; 7: 982-1018
15 Sturm A, Maaser C, Calabrese E. et al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects. J Crohns Colitis 2019; 13: 273-284
16 Narula N, Wong ECL, Colombel JF. et al. Predicting endoscopic remission in Crohnʼs disease by the modified multiplier SES-CD (MM-SES-CD). Gut 2022; 71: 1078-1087
17 Papalia I, Tjandra D, Quah S. et al. Colon capsule endoscopy in the assessment of mucosal healing in Crohnʼs disease. Inflammat Bowel Dis 2021; 27: S25-S32
18 Spada C, Hassan C, Galmiche JP. et al. Colon capsule endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2012; 44: 527-536
19 Korman LY, Delvaux M, Gay G. et al. Capsule endoscopy structured terminology (CEST): proposal of a standardized and structured terminology for reporting capsule endoscopy procedures. Endoscopy 2005; 37: 951-959
20 Leighton JA, Rex DK. A grading scale to evaluate colon cleansing for the PillCam COLON capsule: a reliability study. Endoscopy 2011; 43: 123-127
21 Khanna R, Bouguen G, Feagan BG. et al. A systematic review of measurement of endoscopic disease activity and mucosal healing in Crohn's disease: recommendations for clinical trial design. Inflammat Bowel Dis 2014; 20: 1850-1861
22 Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-174
23 Oliva S, Cucchiara S, Civitelli F. et al. Colon capsule endoscopy compared with other modalities in the evaluation of pediatric Crohnʼs disease of the small bowel and colon. Gastrointest Endosc 2016; 83: 975-983
24 Eliakim R, Yablecovitch D, Lahat A. et al. A novel PillCam Crohnʼs capsule score (Eliakim score) for quantification of mucosal inflammation in Crohn's disease. United Europ Gastroenterol J 2020; 8: 544-551
25 Narula N, Pray C, Wong ECL. et al. Categorizing Endoscopic Severity of Crohnʼs Disease Using the Modified Multiplier SES-CD (MM-SES-CD). J Crohns Colitis 2022; 16: 1011-1019